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Abstract
Background: Human cysticercosis is a zoonotic disease causing severe health disorders and even death. While prevalence
data become available worldwide, incidence rate and cumulative incidence figures are lacking, which limits the
understanding of the Taenia solium epidemiology.
Methodology/Principal findings: A seroepidemiological cohort study was conducted in a south-Ecuadorian community to
estimate the incidence rate of infection with and the incidence rate of exposure to T. solium based on antigen and antibody
detections, respectively. The incidence rate of infection was 333.6 per 100,000 person-years (95% CI: [8.4–1,858] per 100,000
person-years) contrasting with a higher incidence rate of exposure 13,370 per 100,000 person-years (95% CI: [8,730–19,591]
per 100,000 person-years). The proportion of infected individuals remained low and stable during the whole study year
while more than 25% of the population showed at least one antibody seroconversion/seroreversion during the same time
period.
Conclusions/Significance: Understanding the transmission of T. solium is essential to develop ad hoc cost-effective
prevention and control programs. The estimates generated here may now be incorporated in epidemiological models to
simulate the temporal transmission of the parasite and the effects of control interventions on its life cycle. These estimates
are also of high importance to assess the disease burden since incidence data are needed to make regional and global
projections of morbidity and mortality related to cysticercosis.
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Introduction
Human cysticercosis (CC) is a parasitic disease caused by the
development of the metacestode larval stage of Taenia solium
(cysticercus) in the muscles, the central nervous system (causing
neurocysticercosis (NCC)), the subcutaneous tissue and the eyes
(causing subcutaneous and ocular cysticercosis, respectively) [1].
The life cycle of the parasite includes humans as sole definitive
hosts and pigs as main intermediate hosts. Humans get infected by
consumption of raw or undercooked pork infected with cysticerci,
resulting in the development of an adult intestinal tapeworm
(taeniosis). Pigs become infected by ingestion of T. solium eggs
contained in infected human feces, through coprophagic behavior
or via ingestion of contaminated water or food, and develop
porcine CC. Man can also act as a dead-end intermediate host by
accidental ingestion of T. solium eggs [2] and develop human CC.
NCC may cause severe neurological disorders and even death
[3,4]. It is the most important parasitic disease of the central
nervous system and the main cause of acquired epilepsy in T.
solium endemic areas, where NCC is associated with 14.2 to 50%
of the epilepsy cases [5,6]. The maintenance of the parasite life
cycle is associated with poor sanitation, lack of hygiene and
traditional pig rearing systems allowing free roaming of the
animals. Endemic areas have been identified in Asia, Africa and
Latin America [7–10]. In Latin America the infection has been
reported in at least 18 countries and is considered a major public
health problem, especially in poor rural areas [7,8]. The Andean
region of Ecuador and neighboring countries is hyper-endemic for
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cysticercosis [11]. While reliable prevalence data become available
worldwide, they may considerably vary depending on the
diagnostic test used [12–14]. Several tools are available for the
diagnosis of human CC, i.e. imaging and serological techniques.
Serological antigen and antibody detections are valuable tools
when conducting epidemiological studies, since they inform on
infection with and exposure to the parasite, respectively. Taking
the latter distinction into account, studies conducted in Ecuador-
ian endemic rural communities have shown an exposure to the
parasite ranging from 25 to 40% and a proportion of infected
individuals ranging from 2.25 to 4.99% [15–17]. However,
prevalence figures do not inform on the evolution of the number
of positive cases over time and estimates for human cysticercosis
incidence rate and cumulative incidence are lacking, which limits
the understanding of the transmission dynamics of T. solium and
does not allow a precise estimation of its disease burden. Garcı´a et
al. (2001) [18] conducted longitudinal studies in endemic areas of
Peru and Colombia and demonstrated the presence of transient
antibody responses suggesting a high number of antibody
seroconverted cases per year ranging from 8 to 25% of the
population depending on the studied area. Through rule-based
modeling, Praet et al. (2010) [16] simulated the annual antibody
seroconversion rate in an endemic area of Ecuador. They
estimated an annual incidence rate of exposure of people
becoming seropositive of 14 per 100 person-years. On the other
hand, studies estimating both incidence rate of infection and
cumulative incidence are scarce [16,18,19]. Mwape et al. (2013)
[20] reported an incidence rate of infection of 6,300 per 100,000
person-years in a rural community of eastern Zambia. Such
estimates for Latin America are inexistent. For this reason, the
present study aims at estimating the cumulative incidence and the
incidence rate of human CC in an endemic area of Ecuador. A
sero-epidemiological cohort study was conducted to investigate the
transmission dynamics of T. solium among individuals living in a
southern Ecuadorian rural community. This paper reports
estimates of the incidence rates, cumulative incidences of active
infection and exposure rates to T. solium and discusses the
implications for the disease burden assessment and control.
Materials and Methods
Ethical clearance
The protocol used in this study was approved by the Ethical
Committee of the Central University of Ecuador (IRB 00002438)
and by the Ethical Committee of The University Hospital of
Antwerp, Belgium. Written informed consent was obtained from
each individual willing to participate in the study. For participants
aged less than 18 years old written informed consent was also
obtained from a parent or a legal adult representative. Individuals
testing positive for T. solium cysticercosis antigens were referred to
the local health center for follow-up.
Study area, population and design
The study was conducted in the rural parish of Sabanilla (4u
129S, 80u 89W) belonging to the Celica canton in the Southern
Ecuadorian province of Loja. The parish has 1145 inhabitants;
most of them are farmers involved in activities related to
agriculture and animal husbandry. The climate is semi-arid, and
the altitude is 700 meters above sea level. The region is endemic
for T. solium cysticercosis and presents the risk factors for the
transmission of the parasite [15,21]. A sero-epidemiological
community-based cohort study was performed. Three blood
sampling rounds were organized in Sabanilla in a period of 13
months: the first sampling round took place in June 2009 (SR1),
the second in November 2009 (SR2) and the third one in July
2010 (SR3). Based on the three sampling rounds, three periods of
time were defined as follows: a six-month period from June 2009
to November 2009 (P1), a seven-month period from November
2009 to July 2010 (P2), and a total 13-month period from June
2009 to July 2010 (P3).
First, an informative meeting inviting the population to
participate took place at the beginning of the study in collabora-
tion with the local authorities. Then, a census of the population
was conducted based on a door-to-door survey, including
collection of information on age and sex of the inhabitants. After
informed consent, all individuals older than one year willing to
participate and present at the time were blood sampled.
Samples collection and analyses
At each sampling round, 10 ml of blood was collected in dry
tubes. After coagulation and centrifugation, serum was collected
and stored at 220uC until analysis. Two serological diagnostic
tests were performed. (1) The Enzyme Linked Immunosorbent
Assay for the detection of circulating antigens of the metacestode
of T. solium (Ag-ELISA) [22–24]. The sensitivity and specificity of
the Ag-ELISA for detecting active infection in humans are 90%
(95% CI: [80–99%]) and 98% (95% CI: [97–99%]), respectively.
No cross-reaction with other parasites has been reported [13,23].
(2) The Enzyme-Linked Immunoelectrotransfer Blot (EITB) for
the detection of antibodies directed against seven specific T. solium
metacestode glycoproteins [25]. The sensitivity and specificity of
the EITB for detecting exposure to the parasite range from 97% to
98% and from 97% to 100%, respectively [13,25].
Antigen and antibody seroprevalence
The antigen and antibody seroprevalence (Ag and Ab
seroprevalence), as based on the results of the Ag-ELISA and of
the EITB, respectively, were calculated for each sampling round
for the whole population and by sex.
A multinomial Bayesian model adapted from Berkvens et al.
(2006) [26] was used to estimate the true prevalence of T. solium
larval infections for each sampling round based on the antigen
seroprevalence data and on prior information on the test
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T. solium larval infections in Latin America. The simulta-
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were exposed to T. solium eggs, less than 1% of the
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an effective resistance to the parasite acquired through
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African situation, where much higher levels of infection
have been observed. These estimates are of high impor-
tance to understand the epidemiology of T. solium in order
to develop ad hoc cost-effective prevention and control
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solium cysticercosis since longitudinal data are needed to
make regional and global projections of morbidity and
mortality related to cysticercosis.
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characteristics (sensitivity and specificity of the Ag-ELISA). Prior
information was extracted from the available literature [13]. A
uniform distribution with lower and upper limits of 0.80 and
1.00, and 0.97 and 1.00 were used to constrain the sensitivity and
the specificity of the test, respectively. The analysis was conducted
in WinBUGS and R [27,28]. Three chains, 20,000 iterations,
following a burn-in of 5,000 were used to assess the convergence
of the results. Criteria assessing the fit between prior information
and the seroprevalence data were evaluated, i.e. the Bayesian p-
value (Bayesp), the Deviance Information Criterion (DIC) and the
number of parameter effectively estimated by the model (pD)
[26,28].
Seroconversion, seroreversion and incidence rate
First, proportion of change to antigen seropositivity/seronega-
tivity (change to Ag seropositivity/seronegativity) and proportion
of antibody seroconversion and seroreversion (Ab seroconversion
and seroreversion) were calculated to characterize the transmission
dynamics of the disease.
Seroconversion is defined as the change from a negative to a
positive serological test result between 2 sampling rounds; the opposite
is defined as seroreversion [29]. The proportion of Ab seroconversion
and the proportion of change to Ag seropositivity reflect the
cumulative incidence for a defined time period. They were calculated
by dividing the number of new cases by the number of susceptible
individuals (having a negative test result at the previous sampling
round) during a given time. The proportion of Ab seroreversion and
the proportion of change to Ag seronegativity were calculated by
dividing the number of positive tests that turned negative by the
number of positive tests at the previous sampling round.
The incidence rate of infection with the larval stage of T. solium
and the incidence rate of exposure to T. solium eggs were also
calculated based on the results of the antigen and antibody
detection tests, respectively.
The incidence rate was calculated as the number of new
(change from seronegativity to seropositivity) cases in a defined
time period divided by the number of person-time units at risk
during the time-period. Yearly incidence rates were multiplied by
100,000 to be expressed by 100,000 person-years [30,31]. The
person-time unit represents one person for a defined period of
time. The latter was calculated as described in Ngowi et al. (2008)
assuming that the infection occurs uniformly over time and
considering halfway the period between two sampling rounds
[32]. For example, if a person is followed up for six months and
does not seroconvert during this time, this person will contribute
0.5 person-year to the person-time at risk. If a person that is
followed up for the same period but seroconverts during that
period, this person will contribute 0.25 person-year to the person-
time at risk. Yearly incidence rates were calculated based on this
calculation method. Ninety-five % exact Poisson confidence
intervals were calculated using the epitools package in R for all
incidence rates [33].
Data management and statistical analyses
Data were entered in Excel 2010 (Microsoft Office 2010).
Statistical analyses were performed in Stata (Stata Corp., College
Station, TX) and in R: [34]
Fisher exact test was used to compare (1) Ag/Ab seroprevalence
between sex within each sampling round and (2) Ag seropreva-
lence with Ab seroprevalence within each sampling rounds. Also,
McNemar test was performed to compare the sero-Ag and sero-Ab
prevalence between rounds. Multivariate logistic regression
analysis was used to study the association between sero-Ag/Ab
prevalence and age and sex, and this for the three samplings
rounds. The significance level was set at 0.05.Fisher exact test
was used to compare (1) the proportion of Ab seroconversion
with the proportion of antibody seroreversion and the propor-
tion of change to Ag seropositivity with the proportion of
change to Ag seronegativity within periods, (2) the proportions
of Ab seroconversion/seroreversion and the proportions of Ag
change to seropositivity/seronegativity between sexes, (3) the
proportions of Ab seroconversion/seroreversion and the pro-
portions of change to Ag seropositivity/seronegativity between
periods.
In addition, a change point analysis was used to compare the
proportion of Ab seroconversion with the proportion of Ab
seroreversion in function of age. The change point analysis
classifies the population into 2 age groups at different age points
(10, 20, 30, 40, 50, 60, 70, 80 years old). The Fisher exact test was
then used on both age groups in order to identify any change of
significance when comparing the proportions of Ab seroconversion
and seroreversion [16,20,35]. The significance level was set at 0.05
for all statistical analyses.
Results
A total of 967 (84.45%) individuals from the 1145 inhabitants
listed in the census participated in the study. Depending on the
willingness of the individuals to participate, their presence at the
time of sampling and on the quantity of serum available, EITB
was performed on 743 (64.9%), 538 (47%) and 518 (45.2%) sera
for June, November and July, respectively. Ag-ELISA was
performed on 744 (65%), 538 (47%) and 514 (44.9%) sera for
the same time periods. Figure 1 describes in detail sera
availability and individual participation during the three
sampling rounds.
Antigen and antibody seroprevalence
The Ag and Ab seroprevalence for each sampling round for the
whole population and by sex are presented in Table 1. The
prevalence adjusted for misclassification error of T. solium larval
infections was 0.7% (95% Credibility Interval (CI): [0.03–1.75]),
0.7% (95% CI: [0.03–2.00]) and 1.1% (95% CI: [0.05–2.84]) for
SR1, SR2 and SR3, respectively. All except one Ag positive
individuals were also Ab positive in the 3 sampling rounds. Fisher
exact test did not reveal any significant difference of Ag and Ab
seroprevalence between sexes. McNemar test did not reveal any
significant difference of Ag and Ab seroprevalence between
rounds. Ab seroprevalence was significantly higher than Ag
seroprevalence within each sampling round. Multivariate logistic
regression analysis showed a significant positive correlation
between Ab seroprevalence and age.
Table 2 shows the proportions of antigen and antibody
seropositive and/or seronegative individuals who participated in
all 3 sampling rounds and whose sera were available for both
tests (n = 277). Only one individual changed to antigen
seropositivity status throughout the entire study period. Eigh-
teen percent of this restricted population remained antibody
positive throughout the entire study period while about 20% of
the individuals showed at least 1 change of antibody positivity
status.
Seroconversion, seroreversion and incidence rate
The overall incidence rate of human T. solium larval infection
based on -antigen detection was 333.6 per 100,000 person-years
(95% exact Poisson CI: [8.4–1,858] per 100,000 person-years). The
overall incidence rate of exposure to T. solium based on antibody
detection was 13,370 per 100,000 person-years (95% exact Poisson
Human Cysticercosis Incidence in Ecuador
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CI: [8,730–19,591] per 100,000 person-years). Ag proportion of
changes to seropositivity/seronegativity and proportion of Ab
seroconversion/seroreversion by period are represented in
Table 3. Incidence rates estimates for individuals who participated
in at least two of the sampling rounds are given in Table 4.
Fisher exact test did not show any difference of proportion of Ab
seroconversion/seroreversion and proportions of change to Ag
seropositivity/seronegativity between sexes, nor between periods.
Proportion of Ab seroreversion was significantly higher than
proportion of Ab seroconversion for each period (Figure 2). The
change point analysis showed that the proportion of Ab
seroreversion was significantly higher than proportion of Ab
seroconversion until the age of 30 years. After this change point,
the difference was not significant (Figure 3).
Discussion
This is the first study reporting cumulative incidence and
incidence rate figures of human T. solium larval infection in Latin
America. The overall incidence rate of infection in the endemic
rural community of Sabanilla, was 333.6 per 100,000 person-years
(95% exact Poisson CI: [8.4–1,858] per 100,000 person-years),
which suggests that less than 1% of the population becomes
infected yearly with the parasite. In contrast, the incidence rate of
exposure to T. solium is much higher: about 14% of the population
has a yearly contact with the parasite. The latter estimates are in
line with observed and simulated antibody seroconversion rates
ranging from 8 to 25% in Peru, Colombia and Ecuador [16,18].
Proportions of change to Ag seropositivity/seronegativity and
Ab seroconversion and seroreversion were identical in males
and females indicating that both genders get equally infected
with/are equally exposed to the parasite. Moreover, these
proportions did not significantly vary in time (one year period).
On the other hand, proportion of Ab seroreversion was
significantly higher than proportion of seroconversion Ab for
each period and a change point analysis showed that proportion
of Ab seroreversion was significantly higher than proportion of
Ab seroconversion until the age of 30 years. After this change
point, the difference was not significant. These results corrob-
orate the findings of Praet et al. (2010) [16] suggesting a higher
proportion of seroreversion before the age of 40 years due to a
higher number of primary immune responses before this age. In
other words, individuals will serorevert more rapidly before the
age of 30–40 years because primary humoral response is shorter
Figure 1. Sera availability and individual participation during the three sampling rounds. (Format adapted from Mwape et al., 2013). S1,
S2 and S3 stand for first, second and third sampling rounds, Ag-ELISA: Enzyme Linked ImmunosSorbent Assay for the detection of circulating
antigens of the metacestode of T. solium, EITB: Enzyme-Linked Immunoelectrotransfer Blot for the detection of antibodies directed against seven
specific T. solium metacestode glycoproteins.
doi:10.1371/journal.pntd.0002887.g001
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and weaker than secondary response. Thus, the proportion of
seroreversions depends on the immunological status of the
individuals.
The dynamics of infection and exposure in the population,
represented by the proportions of antigen and antibody results
from the individuals who participated in all 3 sampling rounds,
showed that the proportion of infected individuals remains low
and stable during the whole study year, while the proportion of
exposed individuals is remarkably higher. Of note is the high level
of serological status variation with more than 20% of the
Table 1. Antigen and antibody seroprevalence figures (as based on the results of the Ag-ELISA and the EITB, respectively) by sex
and by sampling round.
Seroprevalence Sampling round Sex
Number of positive cases/Total
number of individuals
Percentage of positive cases
[95%CI]a
Antigen SR 1b Female 2/367 0.5 [0.1–2]
Male 5/377 1.3 [0.4–3.1]
Total 7/744 0.9 [0.4–1.9]
SR 2c Female 1/293 0.3 [0–1.9]
Male 4/245 1.6 [0.4–4.1]
Total 5/538 0.9 [0.3–2.2]
SR 3d Female 3/265 1.1 [0.2–3.3]
Male 5/249 2 [0.7–4.6]
Total 8/518 1.5 [0.7–3]
Antibody SR 1b Female 124/364 34.1 [29.2–39.2]
Male 108/379 28.5 [24–33.3]
Total 232/743 31.2 [27.9–34.7]
SR 2c Female 100/293 34.1 [28.7–39.9]
Male 83/245 33.9 [28–40.2]
Total 183/538 34 [30–38.2]
SR 3d Female 80/270 29.6 [24.2–35.5]
Male 77/248 31 [25.3–37.2]
Total 157/518 30.3 [26.4–34.5]
aCI = Binomial exact 95% Confidence Intervals; SR = sampling round;
bSR 1 = June 2009 sampling,
cSR 2 = November 2009 Sampling;
dSR 3 = July 2010 Sampling.
doi:10.1371/journal.pntd.0002887.t001
Table 2. Proportions of antigen and antibody positive and/or negative individuals who participated in the 3 sampling rounds.











SR 1b SR 2c SR 3d
2 2 2 169 61 [54.99–66.7] 276 99.63 [98–99.99]
2 2 + 9 3.24 [1.49–0.6] 1 0.36 [0.01–1.99]
2 + 2 8 2.89 [1.25–5.61] 0 …
2 + + 9 3.24 [1.49–6.07] 0 …
+ 2 2 13 4.69 [2.52–7.89] 0 …
+ 2 + 4 1.44 [0.36–3.66] 0 …
+ + 2 14 5.05 [2.79–8.33] 0 …
+ + + 51 18.4 [14.02–23.49] 0 …
Total 277 277
aCI = Binomial exact 95% Confidence Intervals; SR = sampling round;
bSR 1 = June 2009 sampling,
cSR 2 = November 2009 Sampling;
dSR 3 = July 2010 Sampling.
doi:10.1371/journal.pntd.0002887.t002
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population showing at least one antibody seroconversion/
seroreversion during the year. Together with the prevalence
estimates presented by period, these longitudinal data corroborates
the findings of other studies conducted in Latin America
highlighting a high prevalence of exposure to the parasite but a
low prevalence of active infections. This contrast between
exposure and infection may be linked to an effective resistance
to the parasite acquired through long-term exposure of the
population. In addition, these results confirm the occurrence of
transient antibody responses in individuals living in T. solium
endemic areas and suggest exposure to the parasite without
infection or mild infections that are aborted by the natural
immunity of the individual [20]. Mwape et al. (2013) [20]
conducted a similar community-based longitudinal study in the
Eastern Province of Zambia. While a much higher incidence rate
was observed in the African endemic area, similar higher
proportion of Ab seroreversion than Ab seroconversion and the
presence of transient antibody responses were described. Further
studies are needed to unravel the difference of parasite transmis-
sion patterns in different epidemiological settings. Specifically,
research should focus on identifying the causes for differences in
infection levels. In this context, the identification of tapeworm
carriers in a community should be based on improved methods,
because sensitivity and specificity of conventional coprological
methods are low [36].
Our study has limitations that are mainly due to the inhabitant
proportion of participation. Although 967 individuals from a total
of 1045 inhabitants provided at least one blood sample, 396
provided only one sample and another 283 provided two blood
samples. Compliance in participating in all 3 sampling rounds was
of 288 volunteers despite extensive information sessions prior to the
sampling procedure. The main reason for irregular participation
Table 3. Antigen change to seropositivity/seronegativity test result, antibody seroconversions/seroreversion figures (as based on
the results of Ag-ELISA and EITB respectively) by period.
Test Period Parameter Number of individuals
Percentage of individuals
([95%CI]a)
Antigen P1c Change to seropositivity for 6 months 0/421 0 [0–0.9]b
Change to seronegativity for 6 months 0/3 0 [0–70.8]b
P2d Change to seropositivity for 7 months 1/317 0.3 [0–1.7]
Change to seronegativity for 7 months 0/1 0 [0–97.5]b
P3e Change to seropositivity for 13 months 2/373 0.5 [0.1–1.9]
Change to seronegativity for 13 months 1/1 1 [2.5–100]b
Antibody P1c Seroconversions 26/288 9 [6–12.9]
Seroreversions 25/135 18.5 [12.4–26.1]
P2d Seroconversions 17/226 7.5 [4.4–11.8]
Seroreversions 26/101 25.7 [17.6–35.4]
P3e Seroconversions 24/264 9.1 [5.9–13.2]
Seroreversions 34/120 28.3 [20.5–37.3]
aCI = Binomial exact 95% Confidence Intervals;
bCI = one-sided, 97.5% confidence interval;
cP1 = June–November period;
dP2 = November–July period;
eP3 = June–July period.
doi:10.1371/journal.pntd.0002887.t003
Table 4. Yearly incidence rates for infection and exposure (as based on the results of Ag-ELISA and EITB, respectively) of
individuals who participated in two sampling rounds by period.
Test Period between samplings Number of individuals
Yearly incidence rate ([95% Poisson CI]a)
per 100,000 person-years
Antigen P1b (6 months) 0/421 0[0–1790.7]
P2c (7 months) 1/317 541.6[13.7–3018]
P3d(13 months) 2/373 496.3 [60.1–1792.7]
Antibody P1b (6 months) 26/288 18,909.1[12,352–27,706.2]
P2c (7 months) 17/226 13,399[7,805.4–21,453.1]
P3d (13 months) 24/264 8,791.2[5,632.7–13,080.6]
aCI = Poisson exact 95% Confidence Intervals;
bP1 = June–November period;
cP2 = November–July period;
dP3 = June–July period.
doi:10.1371/journal.pntd.0002887.t004
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was the absence of the individuals for professional duties. Reduced
participation can have an impact on the precision of the estimation
of the incidence rate, however, the participation on the three
sampling rounds is still representative of the total population and
all the participants selected for the incidence rate estimation match
all the selection criteria for this calculation (n = 288 (27.6% (95%
CI: [24.9–30.4]))). Another limitation of the study is the limited
number of samplings and the relatively long sampling intervals
depending on logistic, economic and ethical constraints. In other
words, much more information could have been produced if more
sampling had been organized at shorter time intervals, i.e. the
positivity status of the participants would have been more
accurately monitored over time. The incidence rate estimation
for both infection and exposure is likely to be lower with increasing
intervals between samplings: a proportion of the new infections may
be undetected and the time of occurrence of a new infection
overestimated. A quicker detection of new infections will result in a
decrease of the number of person-years at risk and consequently in
higher estimates of the incidence rate. Finally, even though the tests
used in this study have shown high sensitivity and specificity, false
positive and negative individuals may bias the prevalence and the
incidence rate estimates. Bayesian estimation of infection with T.
solium larva prevalence has been used to estimate the true prevalence
of infection with an exposure to T. solium. The Bayesian estimation
corrects the apparent prevalence at, but does not allow to know the
true infection status at the individual level. Consequently, it does not
allow to estimating the true incidence rate.
In conclusion, the present study underlines the importance of
conducting longitudinal serological follow-up allowing generating
incidence rather than prevalence data to fully understand the
transmission dynamics of the infection and to avoid under/
overestimation of the occurrence of the parasite. Similar cohort
Figure 2. Proportions of Ab seroconversion and seroreversion by time period. White bars represent proportions of Ab seroconversion
whereas grey bars represent proportions of Ab seroreversion; vertical error bars represent the upper and lower limits for the 95% binomial exact
confidence interval; Period 1 stands for the period between Sampling round 1 and sampling round 2 (June–November 2009); Period 2 stands for the
period between sampling round 2 and sampling round 3 (November 2009–July 2010) and Period 3 stands for the period between sampling round 1
and sampling round 3 (June 2009–July 2010).
doi:10.1371/journal.pntd.0002887.g002
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studies assessing the effect of risk factors such as development of
immunity and behavioral factors should be conducted to identify
all the parameters that may influence parasite transmission.
Understanding the transmission dynamics of T. solium is essential
to develop ad hoc cost-effective prevention and control programs.
The estimates generated here may now be incorporated in
epidemiological models to simulate the temporal transmission of
the parasite and the effects of control interventions on its life cycle
[19]. These estimates are also of high importance to assess the
burden of T. solium cysticercosis since incidence data are needed to
make regional and global projections of morbidity and mortality
related to cysticercosis. To this end, the link between the incidence
rate of infection and health outcomes related to human
cysticercosis, such as epilepsy and chronic headache, as well as
the case-fatality ratio still need to be estimated.
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